本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

223.12
-3.8800-1.71%
成交量:39.79万
成交额:8,931.82万
市值:147.68亿
市盈率:17.57
高:228.91
开:225.99
低:222.69
收:227.00
52周最高:282.15
52周最低:186.05
股本:6,618.99万
流通股本:6,553.95万
量比:0.51
换手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):12.70
每股收益(LYR):-4.4176
净资产收益率:118.78%
总资产收益率:9.58%
市净率:9.18
市盈率(LYR):-50.51

数据加载中...

2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/10

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/05

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals